Austin Health

Title
Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study.
Publication Date
2022-12-29
Author(s)
Buntine, Paul
Miller, Joseph
Pope, Alun
Guy, Stephen
Wong, Fang Qi Alex
McDonald, Hannah
Ahmed, Mania
Teow, Kang Hui
Roney, Morgan
Mohammadi, Farzaneh
Aldridge, Emogene
Hackett, Liam
Jenner, Susanna
Davis, Belinda
Subject
ACCIDENT & EMERGENCY MEDICINE
COVID-19
INFECTIOUS DISEASES
Type of document
Journal Article
OrcId
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-1160-9837
0000-0002-5726-1661
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-3666-5261
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1136/bmjopen-2022-065568
Abstract
To determine the negative predictive value (NPV) of the FebriDx point-of-care host response device in patients presenting with symptoms suggestive of COVID-19 infection in a mostly immunised Australian emergency department (ED) population during the late 2021 phase of the COVID-19 pandemic.
Link
Citation
BMJ 2022
Jornal Title
BMJ
ISSN
2044-6055

Files:

NameSizeformatDescriptionLink